ELOXATIN oxaliplatin 50 mg concentrate for injection vial Australien - engelsk - Department of Health (Therapeutic Goods Administration)

eloxatin oxaliplatin 50 mg concentrate for injection vial

sanofi-aventis australia pty ltd - oxaliplatin -

ELOXATIN oxaliplatin 100 mg concentrate for injection vial Australien - engelsk - Department of Health (Therapeutic Goods Administration)

eloxatin oxaliplatin 100 mg concentrate for injection vial

sanofi-aventis australia pty ltd - oxaliplatin -

LIXISENATIDE WINTHROP TREATMENT INITIATION PACK 10mcg (0.05 mg/mL) and 20 mcg (0.1) mg/mL solution for injection injector pen Australien - engelsk - Department of Health (Therapeutic Goods Administration)

lixisenatide winthrop treatment initiation pack 10mcg (0.05 mg/ml) and 20 mcg (0.1) mg/ml solution for injection injector pen

sanofi-aventis australia pty ltd - lixisenatide -

LYXUMIA lixisenatide 10 mcg (0.05mg/mL) solution for injection injector pen Australien - engelsk - Department of Health (Therapeutic Goods Administration)

lyxumia lixisenatide 10 mcg (0.05mg/ml) solution for injection injector pen

sanofi-aventis australia pty ltd - lixisenatide -

LYXUMIA TREATMENT INITIATION PACK 10mcg (0.05 mg/mL) and 20 mcg (0.1) mg/mL solution for injection injector pen Australien - engelsk - Department of Health (Therapeutic Goods Administration)

lyxumia treatment initiation pack 10mcg (0.05 mg/ml) and 20 mcg (0.1) mg/ml solution for injection injector pen

sanofi-aventis australia pty ltd - lixisenatide -

LYXUMIA lixisenatide 20 mcg (0.1 mg/mL) solution for injection injector pen Australien - engelsk - Department of Health (Therapeutic Goods Administration)

lyxumia lixisenatide 20 mcg (0.1 mg/ml) solution for injection injector pen

sanofi-aventis australia pty ltd - lixisenatide -

LIXISENATIDE WINTHROP lixisenatide 20 mcg (0.1 mg/mL) solution for injection injector pen Australien - engelsk - Department of Health (Therapeutic Goods Administration)

lixisenatide winthrop lixisenatide 20 mcg (0.1 mg/ml) solution for injection injector pen

sanofi-aventis australia pty ltd - lixisenatide -

LIXISENATIDE WINTHROP lixisenatide 10 mcg (0.05mg/mL) solution for injection injector pen Australien - engelsk - Department of Health (Therapeutic Goods Administration)

lixisenatide winthrop lixisenatide 10 mcg (0.05mg/ml) solution for injection injector pen

sanofi-aventis australia pty ltd - lixisenatide -

CABAZITAXEL SANOFI Australien - engelsk - Department of Health (Therapeutic Goods Administration)

cabazitaxel sanofi

sanofi-aventis australia pty ltd - cabazitaxel acetone solvate -

PHENERGAN promethazine hydrochloride 25mg tablet blister pack (reformulation) Australien - engelsk - Department of Health (Therapeutic Goods Administration)

phenergan promethazine hydrochloride 25mg tablet blister pack (reformulation)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - promethazine hydrochloride, quantity: 25 mg - tablet, film coated - excipient ingredients: lactose monohydrate; hypromellose; magnesium stearate; maize starch; povidone; macrogol 200; titanium dioxide; indigo carmine; purified water; industrial methylated spirit - allergies: treatment of allergic conditions including some allergic reactions to drugs, urticaria, contact dermatitis, and allergic reactions to insect bites and stings. upper respiratory tract: relief of excesive secretion in the upper respiratory tract as a result of hayfever and allergic rhinitis. nausea and vomiting: antiemetic in vomiting of various causes, including post-operative vomiting, irradiation sickness, drug induced nausea, and motion sickness. sedation: for short term use on the advice of a doctor or pharmacist.